✦ LIBER ✦

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

✍ Scribed by Robert M. Califf; Mitradev Boolell; Steven M. Haffner; M. Angelyn Bethel; John McMurray; Anil Duggal; Rury R. Holman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Baseline Characteristics of the Nateglin

✍ Henry Krum; John J.V. McMurray; Edward Horton; Teresa Gerlock; Bjoern Holzhauer; 📂 Article 📅 2010 🏛 Hindawi Limited 🌐 English ⚖ 126 KB

Incidence of atrial fibrillation in a po

✍ Latini, Roberto; Staszewsky, Lidia; Sun, Jie-Lena; Bethel, M. Angelyn; Disertori 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Epidemiology of risk factors for cardiov

✍ Markku Laakso; Seppo Lehto 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Acarbose in the prevention of cardiovasc

✍ Sophie Delorme; Jean-Louis Chiasson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

65 Epidemiology of risk factors for card

✍ Markku Laakso 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 161 KB

The prevalence of retinopathy in impaire

✍ Diabetes Prevention Program Research Group 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB